The above results thus indicate that combining SBSGL or GAD with cisplatin could induce oxidative stress, leading to the inhibition of p-ERK signaling, and eventually suppression of cell proliferation and promotion of cell death in ovarian tumors (Figure 6). Here, GAD1 is linked to ovarian neoplasm.